348 related articles for article (PubMed ID: 23799357)
1. Impact of hormone therapy on quality of life after menopause.
Utian WH; Woods NF
Menopause; 2013 Oct; 20(10):1098-105. PubMed ID: 23799357
[TBL] [Abstract][Full Text] [Related]
2. Quality of life (QOL) in menopause.
Utian WH
Maturitas; 2007 May; 57(1):100-2. PubMed ID: 17367964
[TBL] [Abstract][Full Text] [Related]
3. On the need to clarify and disseminate contemporary knowledge of hormone therapy initiated near menopause.
Langer RD
Climacteric; 2010 Aug; 13(4):303-6. PubMed ID: 20540591
[TBL] [Abstract][Full Text] [Related]
4. A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women.
Blümel JE; Chedraui P; Baron G; Belzares E; Bencosme A; Calle A; Danckers L; Espinoza MT; Flores D; Gomez G; Hernandez-Bueno JA; Izaguirre H; Leon-Leon P; Lima S; Mezones-Holguin E; Monterrosa A; Mostajo D; Navarro D; Ojeda E; Onatra W; Royer M; Soto E; Tserotas K; Vallejo S;
Menopause; 2011 Jul; 18(7):778-85. PubMed ID: 21407137
[TBL] [Abstract][Full Text] [Related]
5. Quality of life and psychological symptoms in Greek postmenopausal women: association with hormone therapy.
Koundi KL; Christodoulakos GE; Lambrinoudaki IV; Zervas IM; Spyropoulou A; Fexi P; Sakkas PN; Soldatos CR; Creatsas GC
Gynecol Endocrinol; 2006 Dec; 22(12):660-8. PubMed ID: 17162707
[TBL] [Abstract][Full Text] [Related]
6. Hormone therapy in the postmenopausal years: considering benefits and risks in clinical practice.
Genazzani AR; Monteleone P; Giannini A; Simoncini T
Hum Reprod Update; 2021 Oct; 27(6):1115-1150. PubMed ID: 34432008
[TBL] [Abstract][Full Text] [Related]
7. Climacteric medicine: European Menopause and Andropause Society (EMAS) statements on postmenopausal hormonal therapy.
Skouby SO; Barlow D; Samsioe G; Gompel A; Pines A; Al-Azzawi F; Graziottin A; Hudita D; Rozenberg S;
Maturitas; 2004 May; 48(1):19-25. PubMed ID: 15223104
[TBL] [Abstract][Full Text] [Related]
8. Timing hypothesis for postmenopausal hormone therapy: its origin, current status, and future.
Clarkson TB; Meléndez GC; Appt SE
Menopause; 2013 Mar; 20(3):342-53. PubMed ID: 23435033
[TBL] [Abstract][Full Text] [Related]
9. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
Skouby SO; Al-Azzawi F; Barlow D; Calaf-Alsina Erdogan Ertüngealp J; Gompel A; Graziottin A; Hudita D; Pines A; Rozenberg S; Samsioe G; Stevenson JC;
Maturitas; 2005 May; 51(1):8-14. PubMed ID: 15883103
[TBL] [Abstract][Full Text] [Related]
10. Postmenopausal hormones and coronary artery disease: potential benefits and risks.
Lobo RA
Climacteric; 2007 Oct; 10 Suppl 2():21-6. PubMed ID: 17882668
[TBL] [Abstract][Full Text] [Related]
11. A randomized controlled study of taper-down or abrupt discontinuation of hormone therapy in women treated for vasomotor symptoms.
Lindh-Astrand L; Bixo M; Hirschberg AL; Sundström-Poromaa I; Hammar M
Menopause; 2010; 17(1):72-9. PubMed ID: 19675505
[TBL] [Abstract][Full Text] [Related]
12. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.
Harman SM; Naftolin F; Brinton EA; Judelson DR
Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750
[TBL] [Abstract][Full Text] [Related]
13. Current status of hormone therapy and breast cancer.
Norman RJ; MacLennan AH
Hum Reprod Update; 2005; 11(6):541-3. PubMed ID: 16150811
[TBL] [Abstract][Full Text] [Related]
14. Menopause and determinants of quality of life in women at midlife and beyond: the study of health in pomerania (SHIP).
Schwarz S; Völzke H; Alte D; Schwahn C; Grabe HJ; Hoffmann W; John U; Dören M
Menopause; 2007; 14(1):123-34. PubMed ID: 17019378
[TBL] [Abstract][Full Text] [Related]
15. Postmenopausal hormone therapy: new questions and the case for new clinical trials.
Manson JE; Bassuk SS; Harman SM; Brinton EA; Cedars MI; Lobo R; Merriam GR; Miller VM; Naftolin F; Santoro N
Menopause; 2006; 13(1):139-47. PubMed ID: 16607110
[TBL] [Abstract][Full Text] [Related]
16. Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study.
Du Y; Scheidt-Nave C; Schaffrath Rosario A; Ellert U; Dören M; Knopf H
Climacteric; 2009 Aug; 12(4):329-40. PubMed ID: 19437194
[TBL] [Abstract][Full Text] [Related]
17. Cross-cultural comparisons of health-related quality of life in Australian and Japanese midlife women: the Australian and Japanese Midlife Women's Health Study.
Anderson DJ; Yoshizawa T
Menopause; 2007; 14(4):697-707. PubMed ID: 17438514
[TBL] [Abstract][Full Text] [Related]
18. Patterns and predictors of sexual activity among women in the Hormone Therapy trials of the Women's Health Initiative.
Gass ML; Cochrane BB; Larson JC; Manson JE; Barnabei VM; Brzyski RG; Lane DS; LaValleur J; Ockene JK; Mouton CP; Barad DH
Menopause; 2011 Nov; 18(11):1160-71. PubMed ID: 21983008
[TBL] [Abstract][Full Text] [Related]
19. The effect of hormone therapy on women's quality of life in the first year of the Estonian Postmenopausal Hormone Therapy trial.
Veerus P; Hovi SL; Sevón T; Hunter M; Hemminki E
BMC Res Notes; 2012 Apr; 5():176. PubMed ID: 22472039
[TBL] [Abstract][Full Text] [Related]
20. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
Brinton RD
Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
